Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06201416 · ClinicalTrials.gov registry record · Phase 1

Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis

A Phase 1 study of Rheumatoid Arthritis, sponsored by Sonoma Biotherapeutics.

Recruiting
Registry status
Phase 1
Development phase
24
Enrollment target
8
Study locations

NCT06201416 is a Phase 1 study of Rheumatoid Arthritis that is actively recruiting participants, run by Sonoma Biotherapeutics. The registered enrollment target is 24 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (99% lower). The trial reports 8 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06201416, a Phase 1 study of Rheumatoid Arthritis, is actively recruiting participants, sponsored by Sonoma Biotherapeutics.

RECRUITING
Registry status
Phase 1
Development phase
24 participants
Enrollment target
8
Study locations

Study Summary

This study will test the safety and effects of SBT777101 when given as a single dose to subjects with rheumatoid arthritis. It is the first study of this treatment being done in humans. Increasing dose levels will be given after the safety at lower dose levels is shown.

Conditions Studied

Rheumatoid Arthritis

Interventions

  • BIOLOGICAL SBT777101

Study Locations (8)

Massachusetts

  • Tufts University - Boston
  • Massachusetts General Hospital - Boston
  • Brigham and Women's Hospital - Boston

California

  • UCSF Medical Center - San Francisco
  • Stanford Medical Center - Stanford

Arizona

  • Mayo Clinic - Scottsdale

Colorado

  • University of Colorado - Aurora

Illinois

  • Northwestern University - Chicago

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2024-03-06
Est. Completion 2026-03
Phase Phase 1

Sponsor

Sonoma Biotherapeutics

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06201416

The ClinicalTrials.gov registry entry for NCT06201416 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (99% lower). The listed sponsor is Sonoma Biotherapeutics, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which SBT777101 is the first listed.

NCT06201416 reports 8 study locations spanning 5 distinct geographic areas - top geographies include Massachusetts, California, Arizona.

Frequently Asked Questions

What is clinical trial NCT06201416 about?

NCT06201416 is a clinical study titled "Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis". This study will test the safety and effects of SBT777101 when given as a single dose to subjects with rheumatoid arthritis. It is the first study of this treatment being done in humans. Increasing dose levels will be given after the safety at lower dose levels is shown.

What is the current status of trial NCT06201416?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2024-03-06. Estimated completion is 2026-03.

What conditions does trial NCT06201416 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis.

What interventions are being tested in trial NCT06201416?

The interventions under investigation include: SBT777101 (BIOLOGICAL).

Who is sponsoring clinical trial NCT06201416?

This trial is sponsored by Sonoma Biotherapeutics, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06201416 being conducted?

This trial has 8 study locations across Arizona, California, Colorado, Illinois, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Rheumatoid Arthritis

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.